• Make it like cafepharma, but for different industries: over the years we’ve had suggestions for creating a site similar to cafepharma, but for different industries. Now there is a place. Check out CompanyUnderground for company forums in other industries. Don’t see a company? Request it here. Let your friends and family outside the pharma/medical sales space know they now have a safe, anonymous place to talk.


BioOnc Fire Sale sponsored by

Quote












anonymous said:
Remember when Genentech was the leader in Bio Onc? Now the new leaders are Mr Merck and Mr Bristol. Genentech is an aging fighter with diminished skills fighting younger stronger fighters.

Lets look at this logically. Beyond the avastin , herceptin, rituxin death, Esbriet is dragging and never makes its numbers and will be generic in 2021, Xoliar facing 2 huge competitors so sales will definitely decline with 2 strong entrants with good efficacy. Tecentriq is third behind merck and bristol and will get the crumbs from those 2 products. Ocrevus is the only bright spot, and Hemlibra which will also face enormous competition. So now way Roche trades for over $200 per share. Roche will definitely acquire a company
Click to expand...
208.20 and falling. Not good folks. SLT doesn’t like losing money on their RSU’s. Fasten your seatbelts. Blood is in the water. More to come.
 






anonymous said:
208.20 and falling. Not good folks. SLT doesn’t like losing money on their RSU’s. Fasten your seatbelts. Blood is in the water. More to come.
Click to expand...


I would not worry about SLT, when the stock hits 200, it will be Danny and Sevie who you better be concerned about.

I would not want Christy's job, she is doomed for the axe by year-end.
 






Top Bottom
Back
Quote